Hikal Limited Logo

Hikal Limited

HIKAL.NS

(2.8)
Stock Price

386,95 INR

0% ROA

5.81% ROE

62.88x PER

Market Cap.

42.618.990.650,00 INR

0% DER

0.35% Yield

3.77% NPM

Hikal Limited Stock Analysis

Hikal Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Hikal Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (15.05%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

The stock's low PBV ratio (0x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

4 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

5 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

6 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (4.926) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 ROA

The stock's ROA (0%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

8 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

10 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

11 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

Hikal Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Hikal Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Hikal Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Hikal Limited Revenue
Year Revenue Growth
2006 4.357.690.000
2007 4.790.420.000 9.03%
2008 5.728.700.000 16.38%
2009 5.389.520.000 -6.29%
2010 5.022.950.000 -7.3%
2011 7.078.110.000 29.04%
2012 6.592.240.000 -7.37%
2013 8.276.960.000 20.35%
2014 8.590.860.000 3.65%
2015 9.083.810.000 5.43%
2016 10.007.900.000 9.23%
2017 12.985.780.000 22.93%
2018 15.879.040.000 18.22%
2019 15.052.550.000 -5.49%
2020 17.070.520.000 11.82%
2021 19.260.300.000 11.37%
2022 20.047.000.000 3.92%
2023 17.249.200.000 -16.22%
2023 17.846.000.000 3.34%
2024 16.272.000.000 -9.67%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Hikal Limited Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 318.660.000 100%
2013 0 0%
2014 0 0%
2015 306.580.000 100%
2016 344.250.000 10.94%
2017 392.140.000 12.21%
2018 443.680.000 11.62%
2019 482.410.000 8.03%
2020 530.650.000 9.09%
2021 619.360.000 14.32%
2022 708.390.000 12.57%
2023 0 0%
2023 734.300.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Hikal Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 520.310.000
2007 545.030.000 4.54%
2008 530.620.000 -2.72%
2009 416.290.000 -27.46%
2010 425.030.000 2.06%
2011 1.480.150.000 71.28%
2012 84.720.000 -1647.11%
2013 111.050.000 23.71%
2014 119.820.000 7.32%
2015 121.780.000 1.61%
2016 145.310.000 16.19%
2017 116.350.000 -24.89%
2018 156.310.000 25.56%
2019 210.290.000 25.67%
2020 225.260.000 6.65%
2021 426.160.000 47.14%
2022 570.680.000 25.32%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Hikal Limited EBITDA
Year EBITDA Growth
2006 559.600.000
2007 959.050.000 41.65%
2008 954.060.000 -0.52%
2009 1.168.370.000 18.34%
2010 1.195.080.000 2.23%
2011 1.846.850.000 35.29%
2012 1.756.600.000 -5.14%
2013 2.106.840.000 16.62%
2014 1.747.650.000 -20.55%
2015 1.664.020.000 -5.03%
2016 2.072.920.000 19.73%
2017 2.442.270.000 15.12%
2018 2.938.230.000 16.88%
2019 2.709.560.000 -8.44%
2020 3.245.760.000 16.52%
2021 3.402.280.000 4.6%
2022 2.624.800.000 -29.62%
2023 2.340.400.000 -12.15%
2023 2.670.300.000 12.35%
2024 2.320.000.000 -15.1%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Hikal Limited Gross Profit
Year Gross Profit Growth
2006 1.515.540.000
2007 1.733.940.000 12.6%
2008 2.220.700.000 21.92%
2009 2.614.400.000 15.06%
2010 2.207.070.000 -18.46%
2011 3.949.130.000 44.11%
2012 3.883.760.000 -1.68%
2013 4.405.300.000 11.84%
2014 4.185.740.000 -5.25%
2015 4.283.730.000 2.29%
2016 4.746.370.000 9.75%
2017 5.757.670.000 17.56%
2018 7.069.060.000 18.55%
2019 7.037.050.000 -0.45%
2020 7.704.120.000 8.66%
2021 8.927.780.000 13.71%
2022 8.976.700.000 0.54%
2023 8.724.400.000 -2.89%
2023 5.958.000.000 -46.43%
2024 5.024.000.000 -18.59%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Hikal Limited Net Profit
Year Net Profit Growth
2006 191.070.000
2007 474.370.000 59.72%
2008 407.760.000 -16.34%
2009 502.800.000 18.9%
2010 371.710.000 -35.27%
2011 460.340.000 19.25%
2012 252.450.000 -82.35%
2013 638.990.000 60.49%
2014 404.050.000 -58.15%
2015 412.010.000 1.93%
2016 638.790.000 35.5%
2017 772.270.000 17.28%
2018 1.030.780.000 25.08%
2019 844.350.000 -22.08%
2020 1.331.400.000 36.58%
2021 1.604.990.000 17.05%
2022 783.900.000 -104.74%
2023 502.800.000 -55.91%
2023 696.000.000 27.76%
2024 204.000.000 -241.18%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Hikal Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 2
2007 4 75%
2008 3 -33.33%
2009 4 25%
2010 3 -33.33%
2011 4 0%
2012 2 -50%
2013 5 60%
2014 3 -66.67%
2015 3 0%
2016 5 40%
2017 6 16.67%
2018 8 25%
2019 7 -33.33%
2020 11 40%
2021 13 23.08%
2022 6 -116.67%
2023 4 -50%
2023 6 20%
2024 2 -400%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Hikal Limited Free Cashflow
Year Free Cashflow Growth
2006 -52.020.000
2007 -1.118.590.000 95.35%
2008 -542.190.000 -106.31%
2009 697.700.000 177.71%
2010 344.380.000 -102.6%
2011 829.940.000 58.51%
2012 341.310.000 -143.16%
2013 873.180.000 60.91%
2014 536.330.000 -62.81%
2015 1.267.710.000 57.69%
2016 413.940.000 -206.25%
2017 328.330.000 -26.07%
2018 571.610.000 42.56%
2019 1.268.980.000 54.96%
2020 714.190.000 -77.68%
2021 204.190.000 -249.77%
2022 126.900.000 -60.91%
2023 0 0%
2023 -939.280.000 100%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Hikal Limited Operating Cashflow
Year Operating Cashflow Growth
2006 498.670.000
2007 391.840.000 -27.26%
2008 834.490.000 53.04%
2009 1.440.960.000 42.09%
2010 1.080.080.000 -33.41%
2011 1.365.210.000 20.89%
2012 610.490.000 -123.63%
2013 1.387.370.000 56%
2014 1.021.790.000 -35.78%
2015 1.856.070.000 44.95%
2016 1.634.990.000 -13.52%
2017 1.388.140.000 -17.78%
2018 1.855.890.000 25.2%
2019 2.849.300.000 34.87%
2020 2.290.180.000 -24.41%
2021 2.937.330.000 22.03%
2022 3.153.100.000 6.84%
2023 0 0%
2023 1.102.620.000 100%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Hikal Limited Capital Expenditure
Year Capital Expenditure Growth
2006 550.690.000
2007 1.510.430.000 63.54%
2008 1.376.680.000 -9.72%
2009 743.260.000 -85.22%
2010 735.700.000 -1.03%
2011 535.270.000 -37.44%
2012 269.180.000 -98.85%
2013 514.190.000 47.65%
2014 485.460.000 -5.92%
2015 588.360.000 17.49%
2016 1.221.050.000 51.82%
2017 1.059.810.000 -15.21%
2018 1.284.280.000 17.48%
2019 1.580.320.000 18.73%
2020 1.575.990.000 -0.27%
2021 2.733.140.000 42.34%
2022 3.026.200.000 9.68%
2023 0 0%
2023 2.041.900.000 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Hikal Limited Equity
Year Equity Growth
2006 1.839.100.000
2007 1.728.580.000 -6.39%
2008 3.646.770.000 52.6%
2009 3.851.870.000 5.32%
2010 4.004.930.000 3.82%
2011 4.306.030.000 6.99%
2012 4.502.690.000 4.37%
2013 5.047.080.000 10.79%
2014 5.324.820.000 5.22%
2015 5.637.820.000 5.55%
2016 6.049.810.000 6.81%
2017 6.693.850.000 9.62%
2018 7.562.090.000 11.48%
2019 8.165.020.000 7.38%
2020 9.334.020.000 12.52%
2021 10.679.810.000 12.6%
2022 11.334.700.000 5.78%
2023 11.452.600.000 1.03%
2023 11.876.600.000 3.57%
2024 11.876.600.000 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Hikal Limited Assets
Year Assets Growth
2006 5.978.170.000
2007 7.668.370.000 22.04%
2008 10.974.260.000 30.12%
2009 10.504.990.000 -4.47%
2010 10.642.170.000 1.29%
2011 11.317.260.000 5.97%
2012 11.910.810.000 4.98%
2013 12.696.620.000 6.19%
2014 12.920.200.000 1.73%
2015 12.750.210.000 -1.33%
2016 13.794.650.000 7.57%
2017 15.417.080.000 10.52%
2018 16.855.080.000 8.53%
2019 17.679.830.000 4.66%
2020 19.132.200.000 7.59%
2021 22.131.060.000 13.55%
2022 23.854.700.000 7.23%
2023 23.908.500.000 0.23%
2023 24.871.400.000 3.87%
2024 0 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Hikal Limited Liabilities
Year Liabilities Growth
2006 4.139.070.000
2007 5.939.790.000 30.32%
2008 7.327.500.000 18.94%
2009 6.653.120.000 -10.14%
2010 6.637.240.000 -0.24%
2011 7.011.230.000 5.33%
2012 7.408.120.000 5.36%
2013 7.649.540.000 3.16%
2014 7.595.380.000 -0.71%
2015 7.112.390.000 -6.79%
2016 7.744.840.000 8.17%
2017 8.723.230.000 11.22%
2018 9.292.990.000 6.13%
2019 9.514.810.000 2.33%
2020 9.798.180.000 2.89%
2021 11.451.250.000 14.44%
2022 12.520.000.000 8.54%
2023 12.455.900.000 -0.51%
2023 12.994.900.000 4.15%
2024 0 0%

Hikal Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
145.96
Net Income per Share
5.5
Price to Earning Ratio
62.88x
Price To Sales Ratio
2.37x
POCF Ratio
37.03
PFCF Ratio
37.03
Price to Book Ratio
3.59
EV to Sales
2.38
EV Over EBITDA
15.53
EV to Operating CashFlow
37.22
EV to FreeCashFlow
37.22
Earnings Yield
0.02
FreeCashFlow Yield
0.03
Market Cap
42,62 Bil.
Enterprise Value
42,83 Bil.
Graham Number
109.15
Graham NetNet
1.69

Income Statement Metrics

Net Income per Share
5.5
Income Quality
1.7
ROE
0.06
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0.73
EBT Per Ebit
0.6
Ebit per Revenue
0.09
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.38
Operating Profit Margin
0.09
Pretax Profit Margin
0.05
Net Profit Margin
0.04

Dividends

Dividend Yield
0
Dividend Yield %
0.35
Payout Ratio
0
Dividend Per Share
1.2

Operating Metrics

Operating Cashflow per Share
9.33
Free CashFlow per Share
9.33
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.09
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
1,69
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
96.32
Interest Debt per Share
5.06
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.08
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,21 Bil.
Invested Capital
208800000
Working Capital
0,21 Bil.
Intangibles to Total Assets
0
Average Receivables
2,75 Bil.
Average Payables
1,39 Bil.
Average Inventory
1518600000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Hikal Limited Dividends
Year Dividends Growth
2002 5
2003 7 33.33%
2004 5 -20%
2005 7 16.67%
2006 7 0%
2007 7 0%
2008 7 14.29%
2010 8 12.5%
2011 6 -33.33%
2012 6 0%
2013 3 -200%
2014 5 50%
2015 1 -300%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 2 50%
2022 2 -100%
2023 1 0%
2024 1 0%

Hikal Limited Profile

About Hikal Limited

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.

CEO
Mr. Jai Vishwanath Hiremath
Employee
2.061
Address
Great Eastern Chambers
Navi Mumbai, 400614

Hikal Limited Executives & BODs

Hikal Limited Executives & BODs
# Name Age
1 Dr. T. Devanathan
Head of IP & Quality, Pharmaceuticals
70
2 Mr. Jai Vishwanath Hiremath
Founder & Executive Chairman
70
3 Mr. Sameer Jai Hiremath
MD & Executive Director
70
4 Mr. Rajasekhar Reddy Chintakindi
Company Secretary & Compliance Officer
70
5 Mr. Anish Dilip Swadi
Senior President of Animal Health & Business Transformation
70
6 Mr. Kuldeep Jain
Chief Financial Officer
70
7 Mr. Dharmesh Panchal
Chief Technology Officer
70
8 Mr. Ratish Jha
President of Human Resources
70
9 Mr. Manoj Mehrotra
President of Pharmaceuticals Business
70
10 Mr. Vimal Deep Kulshrestha
President of Crop Protection
70

Hikal Limited Competitors

Indoco Remedies Limited Logo
Indoco Remedies Limited

INDOCO.NS

(3.2)
Sequent Scientific Limited Logo
Sequent Scientific Limited

SEQUENT.NS

(0.8)
Granules India Limited Logo
Granules India Limited

GRANULES.NS

(2.5)
Aarti Drugs Limited Logo
Aarti Drugs Limited

AARTIDRUGS.NS

(2.0)
FDC Limited Logo
FDC Limited

FDC.NS

(2.2)